News
08.14.19Rapid Adoption of Carterra’s LSA™ Instrument Drives European Expansion
Carterra® Inc., the world leader in high-throughput antibody screening and characterization, announced today that they have opened a Customer Experience Center (CEC) and office in Munich, Germany. Rapid European adoption of Carterra’s platform has fueled the need for the new office.
News
05.15.19GEN Article: A Therapeutic Antibody Characterization Trinity Accelerates Drug Development
The three core applications of high throughput SPR that form the antibody characterization trinity are capture kinetics, epitope binning, and epitope mapping. Together, they provide a comprehensive characterization of antibody libraries with minimal sample consumption, enabling more confident decisions to be made earlier and obviating the need for preliminary ELISA screening.
News
03.19.19BioTechniques Article on Accelerating Biotherapeutic Discovery with High Throughput SPR
High throughput SPR is revolutionizing antibody screening for drug discovery, allowing screening and characterization to be accomplished in the same step, at the very beginning of the discovery process.
News
02.01.19SLAS Invites Yasmina Abdiche to Present Current Advancements in Antibody Discovery
Accelerate library-to-lead triage of antibody libraries using high throughput SPR.
News
12.18.18Presentation and Poster at Antibody Engineering & Therapeutics
Daniel Bedinger, PhD, our West Coast Senior Field Applications Scientist spoke about accelerating your antibody discovery with high throughput Array SPR.
News
11.28.18Carterra Continues Successful Antibody Discovery Seminars with new US East Coast Event
Industry leaders gather in Cambridge, MA on December 5, 2018 to discuss innovative methods for accelerating antibody discovery.
News
11.15.18Presentation and Poster at PEGS Europe
Phil Leighton, PhD, Director of Molecular Biology at Ligand Pharmaceuticals spoke about epitope mapping of human antibodies from transgenic chickens.
News
09.18.18Antibody Discovery Industry Leaders Speak at Carterra’s September 18, 2018 Seminar
Array SPR has facilitated a paradigm shift in antibody screening, enabling higher information content assays to be conducted earlier in the research pipeline to streamline lead selection. This essentially combines screening and detailed characterization in the same step.
News
09.11.18Expert View Article in Drug Target Review
Explore the full kinetic and epitope diversity of large antibody libraries with high throughput Array SPR (Surface Plasmon Resonance).
News
07.04.18DDW Article on Analytical Biophysical Tools To Accelerate Discovery of Therapeutic Antibodies
The demand for higher throughput analytics is needed to support the paradigm shift that is emerging in the industry towards a deeper appreciation of the epitope diversity offered within an antibody library by applying higher resolution and higher throughput methods for epitope characterization at the earliest stages of research.